U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07300969) titled 'A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression' on Dec. 22.
Brief Summary: The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.
Study Start Date: Dec. 16
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder (MDD)
Intervention:
DRUG: DT-101
DT-101 A
DRUG: DT-101
DT-101 B
DRUG: Placebo
Placebo
Recruitment Status: RECRUITING
Sponsor: Draig Therapeutics Ltd
Disclaimer: Curated by HT Syndica...